AMGN vs MRNA: Which Stock is Better?
Side-by-side comparison of Amgen Inc and Moderna Inc in 2026
AMGN
Amgen Inc
$328.26
MRNA
Moderna Inc
$45.64
Key Metrics Comparison
| Metric | AMGN | MRNA | Winner |
|---|---|---|---|
| Market Cap | $177.63B | $18.11B | AMGN |
| P/E Ratio | 22.89 | N/A | AMGN |
| EPS (TTM) | $14.38 | $N/A | AMGN |
| Revenue Growth | 0.1% | 2.6% | MRNA |
| Gross Margin | 71.4% | -69.9% | AMGN |
Analyze AMGN
Full quant analysis
Analyze MRNA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMGN or MRNA a better investment?
Comparing AMGN and MRNA: Amgen Inc has a market cap of $177.63B while Moderna Inc has $18.11B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMGN and MRNA?
AMGN (Amgen Inc) and MRNA (Moderna Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMGN or MRNA?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AMGN or MRNA?
MRNA has higher revenue growth at 2.6% vs 0.1% for AMGN.
Which company is more profitable: AMGN or MRNA?
Amgen Inc (AMGN) has higher gross margins at 71.4% compared to -69.9% for MRNA.
Which is the larger company: AMGN or MRNA?
Amgen Inc (AMGN) is larger with a market cap of $177.63B compared to $18.11B for MRNA.
Should I buy AMGN or MRNA in 2026?
Both AMGN and MRNA have investment merit. AMGN trades at $328.26 while MRNA trades at $45.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMGN and MRNA stock?
Key differences: Market Cap ($177.63B vs $18.11B), P/E Ratio (22.9x vs N/A), Revenue Growth (0.1% vs 2.6%), Gross Margin (71.4% vs -69.9%).